These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32601988)

  • 21. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.
    Castells X; Casas M; Vidal X; Bosch R; Roncero C; Ramos-Quiroga JA; Capellà D
    Addiction; 2007 Dec; 102(12):1871-87. PubMed ID: 18031423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.
    Amin-Esmaeili M; Farokhnia M; Susukida R; Leggio L; Johnson RM; Crum RM; Mojtabai R
    Addiction; 2024 May; 119(5):833-843. PubMed ID: 38197836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.
    McIntyre RS; Lee Y; Zhou AJ; Rosenblat JD; Peters EM; Lam RW; Kennedy SH; Rong C; Jerrell JM
    J Clin Psychopharmacol; 2017 Aug; 37(4):412-418. PubMed ID: 28590365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine Use in the Elderly: A Systematic Review of the Literature.
    Sassi KLM; Rocha NP; Colpo GD; John V; Teixeira AL
    Curr Neuropharmacol; 2020; 18(2):126-135. PubMed ID: 31660835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
    Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
    Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.
    Solmi M; Fornaro M; Toyoshima K; Carvalho AF; Köhler CA; Veronese N; Stubbs B; de Bartolomeis A; Correll CU
    CNS Spectr; 2019 Oct; 24(5):479-495. PubMed ID: 30460884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
    Leidl D; Takhar P; Li H
    Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
    Ashok AH; Mizuno Y; Volkow ND; Howes OD
    JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychostimulant treatment of cocaine dependence.
    Mariani JJ; Levin FR
    Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
    Bakouni H; Sharafi H; Bahremand A; Drouin S; Ziegler D; Bach P; Le Foll B; Schütz CG; Tardelli V; Ezard N; Siefried K; Jutras-Aswad D
    Drug Alcohol Depend; 2023 Dec; 253():111018. PubMed ID: 37979478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of reduced use and abstinence in multi-site randomized controlled trials of pharmacotherapies for cocaine and methamphetamine use disorders.
    Amin-Esmaeili M; Susukida R; Johnson RM; Farokhnia M; Crum RM; Thrul J; Mojtabai R
    Drug Alcohol Depend; 2021 Sep; 226():108904. PubMed ID: 34304121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placebo.
    Elkrief L; Sharafi H; Bakouni H; McAnulty C; Bastien G; Dubreucq S; Garel N; Trépanier A; Ziegler D; Jutras-Aswad D
    Can J Psychiatry; 2024 Jul; ():7067437241262967. PubMed ID: 39033427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.